Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2009
04/02/2009US20090088344 Method Selecting Highly Specific Probes For HPV Genotype Analysis and the Probes Thereof
04/02/2009US20090087922 Single nucleotide polymorphism analysis of highly polymorphic target sequences
04/02/2009US20090087907 Compositions and Methods for Growth of Pluripotent Cells
04/02/2009US20090087905 VEGF-D polynucleotides and methods of use
04/02/2009US20090087893 Modified Expandase Enzyme and its use
04/02/2009US20090087878 polypeptide useful for production of plant growth regulators; herbicides and heat tolerance
04/02/2009US20090087876 Methods and compositions useful for modulating drug-induced impairment
04/02/2009US20090087843 Molecular markers
04/02/2009US20090087837 Method Of Detecting Streptococcus Pneumoniae, Primer Set For The Detection And Kit For The Detection
04/02/2009US20090087836 Cytokines; fab fragments; fv fragments; monoclonal antibodies
04/02/2009US20090087835 Generating highly specific and highly selective molecular beacon probes by using naturally occurring DNA hairpins present in organisms of interest; identifying a hairpin nucleic acid probe that hybridizes over its entire length to a target nucleic acid molecule
04/02/2009US20090087832 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
04/02/2009US20090087472 Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
04/02/2009US20090087446 Combination motif immune stimulatory oligonucleotides with improved activity
04/02/2009US20090087445 Method for the Redox Potential-Dependent Detection of Target Molecules by Interacting Polypeptides
04/02/2009US20090087439 Compositions and methods for diagnosing or treating psoriasis
04/02/2009US20090087434 Nfia in glial fate determination, glioma therapy and astrocytoma treatment
04/02/2009US20090087431 Methods of treating bone disorders with modulators of axl
04/02/2009US20090087427 Biological materials and uses thereof
04/02/2009US20090087411 Long-acting interferons and derivatives thereof and methods thereof
04/02/2009US20090085006 Activators for oligonucleotide synthesis
04/02/2009DE102007044765A1 Verfahren zur Flüssigphasensynthese eines Polymers A process for the liquid phase synthesis of a polymer
04/02/2009CA2700941A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer
04/02/2009CA2700842A1 High concentration chitosan-nucleic acid polyplex compositions
04/02/2009CA2700164A1 Phage .phi.mru polynucleotides and polypeptides and uses thereof
04/02/2009CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same
04/01/2009EP2042606A1 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic use
04/01/2009EP2042510A2 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleid acid (siNA)
04/01/2009EP2042509A1 Modulators of the function of FAS receptors and other proteins
04/01/2009EP2041267A2 Compositions and methods for enhancing glycerol utilization
04/01/2009EP2040531A2 Transgenic crop plants with improved stress tolerance
04/01/2009EP1856294A4 Key probe compositions and methods for polynucleotide detection
04/01/2009EP1737975A4 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes
04/01/2009EP1472375B1 Gene products differentially expressed in cancerous breast cells and their methods of use
04/01/2009CN101400789A Novel beta-galactoside alpha- 2,6-sialyltransferase, gene coding for the transferase and process for producing the same
04/01/2009CN101400689A Methods of extracting RNA
04/01/2009CN100473724C Novel VIP3 toxins and methods of use
04/01/2009CN100473723C Amplifying repetitive nucleic acid sequences
04/01/2009CN100473659C Hop mosaic virus gene and method for detecting hop mosaic virus
03/2009
03/31/2009US7511198 Transformed maize plant comprising in its genome at least one stably incorporated heterologous nucleic acid molecule comprising a DNA insert; modulating phytate and increasing phosphorus levels; nutritional feeds and foods; gene expression inhibition
03/31/2009US7511132 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition
03/31/2009US7511131 Antisense modulation of apolipoprotein B expression
03/31/2009US7511130 Chimeric rice Os-TubA-3 promoter and methods of use
03/31/2009US7511129 Genetically engineered DNA transfer vector comprising a polynucleotide sequence that encodes a toxin comprising an insecticidal fragment
03/31/2009US7511128 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
03/31/2009US7511127 Compositions, methods and systems for inferring bovine breed
03/31/2009US7511126 Position-independent and tissue specific expression of a transgene in milk of transgenic animals
03/31/2009US7511125 Pyrimidine derivatives for labeled binding partners
03/31/2009US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions
03/31/2009US7511025 Contact tumor cell expressing matrix metalloproteinase 1 with siRNA that has a sequence complementary to part of a matrix metalloproteinase 1 nucleic acid sequence specifically inhibiting synthesis or expression; cancer
03/31/2009US7511024 Factor VII or VIIA-like molecules
03/31/2009US7511005 Lipolytic enzyme elip
03/31/2009US7510874 Stable cell lines expressing HERG1a and HERG1b
03/31/2009US7510860 Xylanases with enhanced thermophilicity and alkalophilicity
03/31/2009US7510857 Thermostable cellulase and methods of use
03/31/2009US7510854 Using transgenic gramnegative bacteria as biorecator for fermentation of methione and lysine for use in medicine, cosmetics and animal feeds
03/31/2009US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2
03/31/2009US7510851 Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia
03/31/2009US7510836 Oligonucleotide for use as diagnostic indicator of seauiterpene endoperoxide resistance in escherichia; identifying and designing modulators to prevent bacterial infection; drug screening
03/31/2009US7510835 Methods for identifying risk of breast cancer and treatments thereof
03/31/2009US7510834 Using restriction fragment length polymorphisms within microsatellite sequences to diagnose arthritic and/or inflammatory disorders
03/31/2009US7510833 Method for examining obesity or leanness
03/31/2009US7510829 Primers for use in the amplification of preferential nucleotide sequences
03/31/2009US7510827 Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup
03/31/2009US7510826 Process for the depletion or removal of endotoxins
03/31/2009CA2494888C Substances for preventing and treating autoimmune diseases
03/31/2009CA2289961C A gene causative of rheumatoid arthritis, method for diagnosing rheumatoid arthritis, and method for identifying causative factors of rheumatoid arthritis
03/31/2009CA2066204C Cystic fibrosis gene
03/26/2009WO2009039173A2 SiRNA SEQUENCE-INDEPENDENT MODIFICATION FORMATS FOR REDUCING OFF-TARGET PHENOTYPIC EFFECTS IN RNAi, AND STABILIZED FORMS THEREOF
03/26/2009WO2009038548A1 Oligonucleotide probes and uses thereof
03/26/2009WO2009038266A1 Method for enhancing serum stability and lowering immune response of sirna down-regulating gene expression of hbv or hcv
03/26/2009WO2009037575A2 Multiplex pcr assay for identification of usa300 and usa400 community-associated methicillin resistant staphylococcal aureus strains
03/26/2009WO2009037402A2 Hpiv-2 variants and medical applications thereof
03/26/2009WO2009021034A3 Methods of treating b-cell cancers
03/26/2009WO2009012263A3 Tissue-specific micrornas and compositions and uses thereof
03/26/2009WO2009006446A3 Methods for cloning small rna species
03/26/2009WO2008156987A9 Riboswitches and methods and compositions for use of and with riboswitches
03/26/2009WO2008148072A3 Disease-associated genetic variations and methods for obtaining and using same
03/26/2009WO2008112008A3 Sensor proteins and assay methods
03/26/2009WO2008106102A9 Inhibitors of rtp801 and their use in disease treatment
03/26/2009WO2008074488A3 Construction and use of transfection enhancer elements
03/26/2009WO2008021419A3 Nucleic acid quantitation from tissue slides
03/26/2009WO2007080597A3 Polynucleotide and polypeptide sequences and methods for diagnosis
03/26/2009WO2007025085A3 Genemap of the human genes associated with crohn's disease
03/26/2009WO2006025808A3 Cross reactive arrays of three-way junction sensors for steroid determination
03/26/2009WO2005077046A3 A composition and method of treating mastitis
03/26/2009WO2005060725A3 Nucleic acid amplification methods
03/26/2009WO2005044977A3 Compositions, splice variants and methods relating to lung specific genes and proteins
03/26/2009WO2005017096A3 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF
03/26/2009WO2005010141A3 Compositions for purifying and crystallizing molecules of interest
03/26/2009WO2004104161A3 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same
03/26/2009WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use
03/26/2009WO2004087871A3 Method of determining gene expression: targeted expressed gene display
03/26/2009US20090083883 D-Amino Acid Selection For Soybean
03/26/2009US20090083879 Brittle Stalk 2 Gene Family And Related Methods And Uses
03/26/2009US20090083874 Production of proanthocyanidins to improve forage quality
03/26/2009US20090083867 Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases
03/26/2009US20090082975 Method of selecting an active oligonucleotide predictive model
03/26/2009US20090082556 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
03/26/2009US20090082555 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics